Accessibility Menu
American Oncology Network logo

American Oncology Network(OTC) AONC

Market Cap$342.17MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)+16%
5 Year+15%
1 Year-7%
1 Month-7%
$11.12
-8.85%
-1.08Today
American Oncology Network last closing stock price
MetricPriceDate
Last closeUSD 11.122026-08-18
American Oncology Network stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+11.31%USD 9.992026-08-11
1 month-7.33%USD 12.002026-07-16
3 month+11.2%USD 10.002026-05-19
Year to date-7.33%USD 12.002025-12-31
1 year-7.33%USD 12.002025-08-18
3 year+6.01%USD 10.492023-08-18
5 year+14.64%USD 9.702021-08-19
Since inception+15.83%USD 9.602021-05-05

American Oncology Network Financials at a Glance

Market Cap

$342.17MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.76B

Net Income (TTM)

-$3.97M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

28.85 (High)

Price

$11.12

Volume

1

Open

$11.12

Previous Close

$11.12

Daily Range

$11.12 - $11.12

52-Week Range

$0.00 - $13.95

Estimated Earnings Date

Aug 18, 2025

AONC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About American Oncology Network

American Oncology Network, Inc. specializes in community-based oncology management, providing comprehensive services to cancer patients. Founded in 2018 and headquartered in Fort Myers, Florida, the company focuses on enhancing patient care through innovative solutions and support.

Products and Services
  • Laboratory services for routine and specialized testing
  • In-house specialty pharmacy services with patient education
  • Care management support services, including nutrition guidance
Growth Outlook
  • Revenue increased to $490.9 million in Q4 2024, up from $324.2 million in Q4 2023
  • Gross profit margin improved to 8.66% in Q4 2024 from 2.66% in Q4 2023
  • Operating cash flow reached $11.9 million in Q4 2024, indicating strong operational efficiency
Financial Highlights
  • Net income of $1.3 million reported in Q4 2024, a significant turnaround
  • Current ratio of 1.53 indicates solid short-term financial health
  • Cash and cash equivalents increased to $62.8 million in Q4 2024, enhancing liquidity
American Oncology Network, Inc. is positioned in the healthcare sector, specifically within medical care facilities, and has shown promising growth in recent quarters. The increase in revenue and improvement in gross profit margin reflect the company's ability to scale operations effectively. The recent financial performance, including a positive net income in Q4 2024, suggests a potential shift towards profitability. The current ratio indicates that the company is well-equipped to meet its short-term obligations, while the substantial cash reserves enhance its financial stability. Overall, American Oncology Network, Inc. presents an intriguing opportunity for investors interested in the healthcare sector, particularly in oncology management.
AI Generated • Jul 28, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

1,914

CEO

Todd Schonherz

Website

www.aoncology.com

Headquarters

Fort Myers, FL 33913, US

AONC Financials

Key Financial Metrics (TTM)

Gross Margin

6.70%

Operating Margin

-0.99%

Net Income Margin

-0.23%

Return on Equity

5.56%

Return on Capital

-10.49%

Return on Assets

-0.84%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$342.17MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

30.77M

Volume

1

Avg. Volume

81.159

Financials (TTM)

Gross Profit

$117.85M

Operating Income

-$17.43M

EBITDA

$1.82M

Operating Cash Flow

$74.12M

Capital Expenditure

-$21.04M

Free Cash Flow

$53.08M

Cash & ST Invst.

$72.64M

Total Debt

$147.37M

American Oncology Network Performance Analysis

American Oncology Network annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 0N/A
20222022-12-31USD 1,149,670,000N/A
20232023-12-31USD 1,279,185,00011.3%
20242024-12-31USD 1,759,484,00037.5%
American Oncology Network sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12024-03-3112.4%
Q22024-06-3019.1%
Q32024-09-308.4%
Q42024-12-314.4%
American Oncology Network annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD 0.20N/A
20222022-12-31USD 0.00N/A
20232023-12-31USD -1.36N/A
20242024-12-31USD -0.69-49.1%
American Oncology Network sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12024-03-31-60.5%
Q22024-06-30103.1%
Q32024-09-30-606.7%
Q42024-12-3198.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2024YOY CHG

Revenue

$490.88M

+51.4%

Gross Profit

$42.53M

+393.4%

Gross Margin

8.66%

N/A

Market Cap

$342.17MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$178.77K

N/A

Employees

1,914

N/A

Net Income

$1.32M

+135.1%

EBITDA

$9.44M

+158.3%

Quarterly Fundamentals

Name
Q4 2024YOY CHG

Total Cash

$72.64M

+13.6%

Total Debt

$147.37M

+14.8%

Accounts Receivable

$189.63M

+14.9%

Inventory

$60.71M

+36.2%

Long Term Debt

$135.14M

+8.1%

Short Term Debt

$12.23M

-22.4%

Return on Assets

-0.84%

N/A

Return on Invested Capital

-6.88%

N/A

Free Cash Flow

$5.60M

+138.1%

Operating Cash Flow

$11.93M

+199.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
DMTRF3-D Matrix, Ltd.
$2.50+0.00%
MFCSFMedical Facilities Corporation
$11.28-0.44%
EVGRFChina Evergrande New Energy Vehicle Group Limited
$0.00+0.00%
SLNCFSilence Therapeutics plc
$5.50+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
IBITiShares Bitcoin Trust
$41.20+0.06%
INTCIntel
$92.13-0.01%
MSTRStrategy
$112.39+0.08%
ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF
$17.55+0.11%

Questions About AONC

What is the current price of American Oncology Network?

American Oncology Network is trading at $11.12 per share.

What is the 52-week range for American Oncology Network?

Over the past 52 weeks, American Oncology Network has traded between $0.00 and $13.95.

How much debt does American Oncology Network have?

As of the most recent reporting period, American Oncology Network reported total debt of $150.74M.

How much cash does American Oncology Network have on hand?

American Oncology Network reported $62.85M in cash and cash equivalents in its most recent financial results.

What is American Oncology Network’s dividend yield?

American Oncology Network does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services